(New York, NY – February 9, 2026) – High-risk pregnancy specialists from the Raquel and Jaime Gilinski Department of Obstetrics, Gynecology and Reproductive Science at the Icahn School of Medicine at Mount Sinai are presenting research at the Annual Pregnancy Meeting of the Society for Maternal-Fetal Medicine (SMFM) in Las Vegas until February 13. These presentations include analysis of an AI-assisted tool to diagnosis severe congenital heart defects from fetal scans and a machine learning model that could predict placenta accreta spectrum.
The Mount Sinai doctors and researchers are available for interview about their research findings and can also provide commentary on other women’s health studies, topics, and breaking news.
PRESENTATIONS and POSTER SESSIONS
***All abstracts are under embargo until the below listed times***
Wednesday, February 11, 2026
Preconception prediction of placenta accreta spectrum using machine learning and EMR data
Wednesday, February 11, 2026, 10:30 a.m. – 12:00 p.m. PST
Presenter: Henri Mitchell “Mitch” Rosenberg, MD, Maternal Fetal Medicine Attending Physician at Mount Sinai
• Preconception machine learning models using Electronic Medical Record data can identify patients at elevated risk for placenta accreta spectrum, a serious pregnancy complication, with high sensitivity and specificity. The AI model can identify anemia as a novel predictor, highlighting the potential role of modifiable risk factors, and serve as an early screening to help facilitate risk counseling, referral, and personalized care planning before conception.
Neonatal respiratory outcomes by delivery indication following antenatal corticosteroid administration
Wednesday, February 11, 2026, 10:30 a.m. – 12:00 p.m. PST
Presenter: Sara E. Edwards, MD, Maternal Fetal Medicine Fellow at Mount Sinai
• Prior studies demonstrate improved preterm neonatal outcomes with administration of antenatal corticosteroids, or medications given to pregnant people at risk of preterm birth. However, no studies have investigated the interaction of this fixed dose medication with maternal weight or body mass index. This study assessed the association of maternal weight and body mass index with neonatal outcomes after administration of the medication. The researchers hypothesize that steroids would have reduced efficacy at improving neonatal respiratory outcomes in cases of maternal obesity.
Labor management mediates racial and ethnic disparities in mode of delivery among an NTSV cohort
Wednesday, February 11, 2026, 10:30 a.m. – 12:00 p.m. PST
Presenter: Nicola F. Tavella, MPH, Clinical Research Program Director for Maternal Fetal Medicine in the Raquel and Jaime Gilinski Department of Obstetrics, Gynecology and Reproductive Science at the Icahn School of Medicine at Mount Sinai
• Racial and ethnic disparities persist in labor and delivery management, and its impact on maternal and neonatal outcomes are under studied. However, further rigorous investigations can potentially help reduce perinatal health inequities. This study examined racial and ethnic disparities in labor management and the mediating effects on the risk of cesarean delivery among a Nulliparous, Term, Singleton, Vertex (NTSV) cohort, or group of first-time mothers with a single, full-term fetus in the head-down position.
Thursday, February 12, 2026
Recurrent neural network model for placenta accreta spectrum according to surgical technique in prior cesarean
Thursday, February 12, 2026, 10:30 a.m. – 12:00 p.m. PST
Presenter: Tess Cersonsky, MD, OBGYN Resident at Mount Sinai
• Placenta accreta spectrum (PAS), a serious pregnancy complication, has risen in incidence with the increase in cesarean delivery rates in the United States. While prior studies have examined uterine closure techniques—such as endometrium-free closure—and their association with PAS, less is known about how surgical variations at cesarean may influence future PAS risk. The researchers evaluated if variations in surgical technique, including closure of abdominal layers and suture type, during antecedent cesarean delivery can predict PAS risk in a subsequent pregnancy.
Impact of AI Support on Completion of Fetal Cardiac Screening in an MFM Ultrasound Center
Thursday, February 12, 2026, 10:30 a.m. – 12:00 p.m. PST
Presenter: Jennifer Lam-Rachlin, MD, Maternal Fetal Medicine Attending Physician at Mount Sinai West
• Prenatal diagnosis of severe congenital heart defects is key for improving neonatal outcomes. AI for congenital heart defects screening shows strong early evidence and is now entering real-world validation. In this study, the researchers aim to evaluate the impact of an AI-supported tool that flags suspicious findings for severe congenital heart defects at an AIUM-certified Prenatal Diagnostic Center.
Associations of a Composite Social Vulnerability Index with Adverse Pregnancy Outcomes
Thursday, February 12, 2026, 10:30 a.m. – 12:00 p.m. PST
Presenter: Nicola F. Tavella, MPH, Clinical Research Program Director for Maternal Fetal Medicine in the Raquel and Jaime Gilinski Department of Obstetrics, Gynecology and Reproductive Science at the Icahn School of Medicine at Mount Sinai
• Exposure to socioenvironmental stress worsens the risk of adverse pregnancy outcomes. Indices measuring social vulnerability cannot individually capture the complex dynamics of the social environment. This study examined whether a composite social vulnerability index (CSVI) was independently associated with adverse pregnancy outcomes.
Neighborhood-level exposure to gun violence and adverse pregnancy outcomes
Thursday, February 12, 2026, 10:30 a.m. – 12:00 p.m. PST
Presenter: Sara E. Edwards, MD, Maternal Fetal Medicine Fellow at Mount Sinai
• Adverse pregnancy outcomes are associated with exposure to prenatal stress. The researchers examined whether exposure to neighborhood-level gun violence during pregnancy was associated with increased risk of adverse pregnancy outcomes.
Pregnancy outcomes of successive higher-order cerclage
Thursday, February 12, 2026, 10:30 a.m. – 12:00 p.m. PST
Presenter: Ivie Odiase, MD, OBGYN Resident at Mount Sinai West
• Preeclampsia, a hypertensive disorder occurring during pregnancy, presents with hypertension and proteinuria—endangering maternal and perinatal health through risks like preterm birth and maternal organ dysfunction. Aspirin, with its anti-inflammatory and antiplatelet effects, has proven effective in preventing preeclampsia. The American College of Obstetricians and Gynecologists (ACOG) recommend 81mg aspirin daily as a preventive measure for preeclampsia. This study examines the universal implementation of that advice targeting pregnant individuals with high or multiple moderate risk factors.
Pre-pregnancy risk factors for placenta accreta spectrum: Understanding data structure using principal component analysis
Thursday, February 12, 2026, 3:30 – 5:00 p.m. PST
Presenter: Tess Cersonsky, MD, OBGYN Resident at Mount Sinai
• Although certain risk factors for placenta accreta spectrum (PAS) such as prior cesarean, uterine surgery, or placenta previa are well established, many causal factors remain poorly understood. This limits expert ability to predict and prepare for PAS deliveries, which carry substantial risk for severe maternal morbidity and mortality. The researchers investigate the underlying data in a PAS cohort, using principal component analysis to help build clinical models that focus on important risk factors for PAS.
Maternal body mass index and neonatal respiratory outcomes following antenatal corticosteroid administration
Thursday, February 12, 2026, 3:30 – 5:00 p.m. PST
Presenter: Sara E. Edwards, MD, Maternal Fetal Medicine Fellow at Mount Sinai
• Prior studies have demonstrated improved preterm neonatal outcomes with administration of antenatal corticosteroids (ACS). However, no studies have investigated the interaction of this fixed dose medication with maternal weight or body mass index. This study assessed the association of maternal weight and body mass index with neonatal outcomes after ACS administration. The researchers hypothesize that steroids would have reduced efficacy at improving neonatal respiratory outcomes in cases of maternal obesity.
Addressing perinatal health disparities through institution-wide offering of elective inductions of labor at 39 weeks
Thursday, February 12, 2026, 3:30 – 5:00 p.m. PST
Presenter: Nicola F. Tavella, MPH, Clinical Research Program Director for Maternal Fetal Medicine in the Raquel and Jaime Gilinski Department of Obstetrics, Gynecology and Reproductive Science at the Icahn School of Medicine at Mount Sinai
• Socio-structural barriers yield disparate perinatal outcomes. Identifying broad policies that reduce health disparities can inform targeted interventions. The Social Vulnerability Index (SVI) quantifies neighborhood-level, socio-structural adversity. The researchers examined if expanding access to elective inductions of labor (IOL) post-ARRIVE trial changed SVI-based perinatal disparities.
###
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across seven hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.
END